Pittsburgh, Jan 06,2004
Download this FTI news release (PDF).

Chemical technology company Fluorous Technologies, Inc., announced that US Patent 6,673,539 “Fluorous Tagging Compounds and Methods of Use Thereof”, exclusively licensed from the University of Pittsburgh, issued today. The patent broadly covers the use of fluorous tags and separation techniques in conjunction with solid support chemistry. This tagging strategy has recently been demonstrated in peptide and oligomer synthesis and the company is actively seeking partners to further explore commercial applications in these areas.

“We are excited that this groundbreaking patent has issued. This addition to our already strong intellectual property position in fluorous chemistry will allow us to enter new drug discovery markets” said Dr. Philip E. Yeske, President and Chief Executive Officer of Fluorous Technologies. “We intend to capitalize on this patent by finding strong partners in both research as well as marketing.”

Fluorous Technologies, Inc. (FTI) is a chemical technology company dedicated to the development and commercialization of fluorous products focused at the life science market. The company uses patented technology to solve synthesis and separation problems spanning the entire drug discovery and development process. FTI further leverages its enabling technology through service contracts, licenses, and collaborations. For more information, please visit www.fluorous.com.

Fluorous Technologies

412-826-3050
or toll-free 877-FLUOROFLASH